Histological analysis of α-synuclein pathology in the circadian system in Parkinson’s disease
Objective: Assessment of severity of α-synuclein pathology in the circadian system in patients with Parkinson’s disease (PD). Background: Circadian system is responsible for the 24-hour…Association of CSF biomarkers with motor and non-motor features in moderately advanced Parkinson’s disease cohort: the BioFIND study
Objective: Evaluate associations between CSF biomarkers of neurodegeneration and clinical phenotype in Parkinson’s disease (PD) participants of the BioFIND cohort. Background: Levels of CSF α-synuclein…Circadian and Homeostatic Modulation of Multi-unit Activity in Dopaminergic and Striatal Structures
Objective: The aim of this study is to investigate the circadian and homeostatic modulation of the multi-unit activity of dopamineric and striatal neuronal structures. Background:…Association of impaired melatonin secretion with sleep disturbance in Parkinson’s disease
Objective: To clarify if impaired melatonin secretion is associated with daytime or nighttime sleep disturbances in patients with Parkinson’s disease (PD). Background: PD is associated…Sleep architecture in Parkinson´s disease and Parkinson’s disease associated dementia
Objective: To evaluate the differences in early sleep architecture between patients with Parkinson’s disease (PD) and Parkinson’s disease associated dementia (PDD). Background: Disorders of sleep…Circadian dysfunction in Parkinson’s disease: Effects on impaired gait initiation and locomotion
Objective: To investigate the impact of circadian rhythm (CR) and time of the day on the magnitude of motor impairments during gait initiation and continuation…Comparative study of the substantia nigra echogenicity and 123-I ioflupane SPECT in patients with REM behavior disorder
Objective: To compare (1) the echogenicity of substantia nigra (SN) in subjects with idiopathic REM behavior disorder (iRBD) and healthy controls and (2) to determine…